Updates in perioperative coagulation: physiology and management of thromboembolism and haemorrhage.
Understanding of blood coagulation has evolved significantly in recent years. Both new coagulation proteins and inhibitors have been found and new interactions among previously known components of the coagulation system have been discovered. This increased knowledge has led to the development of various new diagnostic coagulation tests and promising antithrombotic and haemostatic drugs. Several such agents are currently being introduced into clinical medicine for both the treatment or prophylaxis of thromboembolic disease and for the treatment of bleeding. This review aims to elucidate these new concepts and to outline some consequences for clinical anaesthesia and perioperative medicine.
Bombeli
T
T
Coagulation Laboratory, Division of Haematology, University Hospital of Zürich, Sternwartstrasse 14, CH-8091 Zürich, Switzerland.
Spahn
D R
DR
D001777:Blood Coagulation; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006488:Hemostasis, Surgical / Q000379:methods*; D006801:Humans; D019990:Perioperative Care / Q000379:methods; D018570:Risk Assessment / Q000379:methods; D013923:Thromboembolism / Q000628:therapy*
D005343:Fibrinolytic Agents